Avidity Partners Management’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-68,000
| Closed | -$1.39M | – | 72 |
|
|
2025
Q1 | $1.39M | Sell |
68,000
-286,000
| -81% | -$5.85M | 0.27% | 56 |
|
|
2024
Q4 | $9.1M | Sell |
354,000
-535,700
| -60% | -$13.8M | 0.89% | 39 |
|
|
2024
Q3 | $14.8M | Buy |
889,700
+330,400
| +59% | +$5.48M | 0.75% | 50 |
|
|
2024
Q2 | $10.7M | Buy |
559,300
+84,300
| +18% | +$1.62M | 0.46% | 60 |
|
|
2024
Q1 | $11.2M | Buy |
+475,000
| New | +$11.2M | 0.36% | 68 |
|